Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency
Crossref DOI link: https://doi.org/10.1007/s11136-018-2025-y
Published Online: 2018-11-19
Published Print: 2019-02-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Salek, M. S. http://orcid.org/0000-0002-4612-5699
Ionova, T.
Johns, J. R.
Oliva, E. N.
Text and Data Mining valid from 2018-11-19
Version of Record valid from 2018-11-19
Article History
Accepted: 9 October 2018
First Online: 19 November 2018
Compliance with ethical standards
:
: The authors declare that there are no commercial or financial conflicts of interest.